Geroscience

Attilio Names Buck Institute CEO Eric Verdin Co-Chairman

Image
Attilio Names Buck Institute CEO Eric Verdin Co-Chairman

St. Petersburg, Florida – October 16, 2026 -- Attilio, a longevity platform launched in September 2026, has appointed Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging, as Co-Chairman. The company prices the Dr. Verdin Baseline Assessment(TM), built on his research, at $2,500 per member.

Verdin brings Buck Institute research access to Attilio's care model

The Buck Institute describes itself as the first independent biomedical research institute focused solely on aging and age-related disease. Founded in Novato, California, it helped establish the field known as geroscience.